Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as an Elite provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as an Elite provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.

Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is rated as an Elite provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.

James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as an Elite provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy.

T. Y. Alvin Liu, M.D. is the James P. Gills, Jr. M.D., and Heather Gills Rising Professor of AI and the founding director of the Wilmer Precision Ophthalmology Center of Excellence. He is originally from Hong Kong, and speaks fluent Cantonese and Mandarin. He attended Phillips Exeter Academy in Exeter, New Hampshire, and graduated from Cornell University with a dual major in biology and economics. He received his M.D. from Columbia University in 2012, and completed his residency (2016) and fellowship (surgical and medical retina- 2018) at Johns Hopkins. He is subspecialty-trained in the medical and surgical treatment of vitreoretinal diseases, including age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vascular occlusion, retinal detachment, vitreous hemorrhage, epiretinal membrane and macular hole. Dr. Liu's research interests center on the application of artificial intelligence in the screening, diagnosis, prognostication and treatment of ophthalmic diseases, with a specific focus on vitreoretinal diseases such as age-related macular degeneration and diabetic retinopathy. In addition, he is involved in research on the pathogenesis of and treatment for pathologic myopia and the management of severe ocular trauma. Videos Dr. Tin Yan Alvin Liu Recent News Articles and Media Coverage AI Speeds Diabetic Retinopathy Diagnosis Without Specialist. Medscape August 28, 2018 AI Screening for Diabetic Retinopathy Moves to Retail Clinics. Medscape November 26, 2019 How Artificial Intelligence is Primed to Change Ophthalmology. Ophthalmology Advisor May 14, 2021 Medicine's first autonomous AI could prevent blindness due to diabetes. Stat News December 16, 2021 Innovations in Eye Care: How Technology is Transforming Ophthalmology. HealthTech November 29, 2022 Time to go multicultural. Retina Today March 1, 2023 How deep learning may play a role in predicting retinitis pigmentosa visual impairment. Ophthalmology Times March 14, 2023 AI in retinal diagnostics. Zhaoke Ophthalmology March 22, 2023 Macular Degeneration. Spotlight on Geographic Atrophy. Advances in Treatment. WebMD April 23, 2023 ARVO 2023: T.Y. Alvin Liu, MD discusses predictive AI and its application in ophthalmology. Modern Retina April 25, 2023 ASCRS: Prediction of imminent conversion to neovascular AMD using deep learning and 3D OCT volumes. OptometryTimes May 5, 2023 Adopting and regulating AI in healthcare. BNN Bloomberg May 29, 2023 AI could increase health equity and boost adherence to annual eye examination in patients with diabetes. Modern Retina June 21, 2023 As more Marylanders grow older, a debilitating eye disease is gaining ground. The Baltimore Banner June 26, 2023. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Usher Syndrome Type 2A, Cone Rod Dystrophy Amelogenesis Imperfecta, Cone-Rod Dystrophy, and Stargardt Macular Degeneration.

Fasika A. Woreta, M.D., M.P.H. is a cornea and cataract specialist and the Eugene de Juan, M.D. Professor of Ophthalmic Education at Wilmer Eye Institute’s Baltimore and Columbia locations. Her expertise is in in corneal and external eye diseases, including complex cataracts and anterior segment reconstruction following trauma. Dr. Woreta is currently the director of the Eye Trauma Center and the director of the Ophthalmology Residency Program at the Wilmer Eye Institute. An associate professor of ophthalmology, Dr. Woreta received her M.D. degree from the Johns Hopkins University School of Medicine and her M.P.H. degree from the Johns Hopkins Bloomberg School of Public Health. She completed her residency in ophthalmology at the Wilmer Eye Institute, then completed a fellowship in cornea and refractive surgery at the Bascom-Palmer Eye Institute at the University of Miami, as well as an accident and emergency and cataract fellowship at Moorfields Eye Hospital. Dr. Woreta is rated as an Experienced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Endophthalmitis, Cataract, Hyphema, Cataract Removal, and Corneal Transplant.

Dean S. Glaros, M.D., is an assistant professor of ophthalmology at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a comprehensive ophthalmologist with special interests in cataract surgery, glaucoma, diabetes, dry eye and other medical eye conditions. He also performs routine eye exams for patients age 6 and older. Dr. Glaros received his medical degree from the University of Maryland and performed his medical internship at the University of North Carolina Affiliate Program. He completed his residency in ophthalmology at the University of Maryland. Before joining the Wilmer faculty, he was in private practice in the Baltimore area. Dr. Glaros is a member of the American Academy of Ophthalmology. Dr. Glaros is rated as an Experienced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Cataract, X-Linked Retinal Dysplasia, X-Linked Juvenile Retinoschisis, and Glaucoma.

Dr. Sherry Narang Kalla is an assistant professor of ophthalmology at the Johns Hopkins School of Medicine. Her areas of clinical expertise includes comprehensive ophthalmology. Dr. Narang Kalla received her undergraduate degree from Gannon University, where she was a Hamlot Scholar. In 2005, she earned her medical degree from Drexel University College of Medicine. She completed a pediatric residency at Children’s National Medical Center in 2009, and her ophthalmology residency at SUNY Downstate Medical Center in 2013, where she served as chief administrative resident. Prior to joining Johns Hopkins, Dr. Narang Kalla served as an Assistant Clinical Professor of Pediatrics and an ER Clinical Associate at Children’s National Medical Center. She has been in private practice since 2013, at Patapsco Eye MDs, in Columbia, Maryland. Dr. Narang Kalla is a member of the American Academy of Ophthalmology, the American Academy of Pediatrics, and the American Association of Physicians of Indian Origin. Dr. Kalla is rated as an Experienced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Cataract, Glaucoma, Dry Eye Syndrome, and Blepharitis.

Lenard Hammer is an Ophthalmologist in Columbia, Maryland. Dr. Hammer is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Glaucoma, and Geographic Atrophy. Dr. Hammer is currently accepting new patients.

Olga Shif is an Ophthalmologist in Elkridge, Maryland. Dr. Shif is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Central Serous Chorioretinopathy, and Vitrectomy. Dr. Shif is currently accepting new patients.

Anshu Sinha is an Ophthalmologist in Columbia, Maryland. Dr. Sinha is rated as an Experienced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Glaucoma, Allergic Conjunctivitis, Conjunctivitis (Pink Eye), and Ocular Hypertension (OHT).

Douglas A. Jabs, M.D., M.B.A. is an internationally-recognized expert in the evaluation and management of patients with uveitis and related immune-mediated ocular disorders, particularly on the use of immunosuppression to treat severe ocular inflammatory diseases. Founder of the Division of Ocular Immunology and Uveitis at Wilmer, he now is the Director of the Center for Clinical Trials and Evidence Synthesis at the Johns Hopkins University Bloomberg School of Public Health. Dr. Jabs is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Uveitis, CMV Retinitis, Scleritis, Cataract Removal, and Trabeculectomy.

Mariam Mathai is an Ophthalmologist in Columbia, Maryland. Dr. Mathai is rated as an Advanced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), and Vitrectomy. Dr. Mathai is currently accepting new patients.

Alan Malouf is an Ophthalmologist in Columbia, Maryland. Dr. Malouf is rated as an Advanced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Dry Eye Syndrome, Cataract, Glaucoma, and Allergic Conjunctivitis. Dr. Malouf is currently accepting new patients.

Scott Laborwit is an Ophthalmologist in Elkridge, Maryland. Dr. Laborwit is rated as an Advanced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Cataract, Presbyopia, Astigmatism, Glaucoma, and Cataract Removal.

Malin Howard is an Ophthalmologist in Columbia, Maryland. Dr. Howard is rated as an Experienced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Facial Paralysis, Recurrent Peripheral Facial Palsy, Bell's Palsy, and Cataract.

Jonathan Etter is an Ophthalmologist in Columbia, Maryland. Dr. Etter is rated as an Experienced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Interstitial Keratitis, Cataract, Blepharitis, and Sjogren Syndrome. Dr. Etter is currently accepting new patients.

Parvathy Pillai is an Ophthalmologist in Columbia, Maryland. Dr. Pillai is rated as an Experienced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Cataract, Neuroretinitis, Glaucoma, and Uveitis. Dr. Pillai is currently accepting new patients.

Scott Becker is an Ophthalmologist in Columbia, Maryland. Dr. Becker is rated as an Experienced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Blepharitis, Sjogren Syndrome, Interstitial Keratitis, and Cataract. Dr. Becker is currently accepting new patients.

Brian Winter is an Ophthalmologist in Columbia, Maryland. Dr. Winter is rated as an Experienced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Ocular Hypertension (OHT), Glaucoma, Chalazion, and Eyelid Bump.